Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Monitoring of CD38high expression in peripheral blood CD8+ lymphocytes in patients after kidney transplantation as a marker of cytomegalovirus infection

Olga Ticha, Martina Stouracova, Milan Kuman, Pavel Studenik, Tomas Freiberger, Jiri Litzman

. 2010 ; 24 (1) : 50-56. [pub] 20101014

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12027319

Grantová podpora
NS9894 MZ0 CEP - Centrální evidence projektů

BACKGROUND: Cytomegalovirus (CMV) infection is a life-threatening complication after solid organ transplantation. It usually appears in the first months after transplantation as a consequence of immunosuppression. The goal of this study was to evaluate the clinical significance of CD38(high)/CD3(+)8(+) percentages in the detection of CMV infection in patients after kidney transplantation. METHODS: In this retrospective study, 269 patients were monitored 2-3 months after renal transplantation for the percentage of CD38(high)/CD3(+)8(+) lymphocytes estimated by flow cytometry and for the number of CMV DNA copies in peripheral blood using a real-time polymerase chain reaction. RESULTS: CMV infection was diagnosed in 12 (4.5%) patients between the 31st and 63rd days after transplantation, and all of them had percentages of CD38(high)/CD3(+)8(+) T lymphocytes above 20%. In 4 of them, CMV DNAemia in peripheral blood was not detected, and 2 of these suffered from tissue-invasive CMV disease. In 7 patients with CMV DNAemia, the CD38(high)/CD3(+)8(+) T lymphocyte percentage did not exceed 20%, and these patients did not develop CMV infection requiring antiviral treatment. In 23 additional patients, a CD38(high)/CD3(+)CD8(+) percentage above 20% was recorded without CMV DNAemia. All of the remaining 234 patients never exceeded the arbitrary limit of 20%. The estimated sensitivity and specificity were 100% and 91% using clinical decision on the presence of CMV infection as a reference value, respectively. The estimated negative predictive value was 100%; however, the estimated positive predictive value was quite low (34%). CONCLUSIONS: The CD38(high)/CD3(+)8(+) lymphocyte percentage seems to be a useful additional diagnostic marker for CMV infection in patients after kidney transplantation, especially when patients are in the risk of a tissue-invasive disease when CMV DNA copies may not be detectable in peripheral blood.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12027319
003      
CZ-PrNML
005      
20160301181124.0
007      
ta
008      
120816s2010 enk f 000 0#eng||
009      
AR
024    7_
$a 10.1016/j.trim.2010.10.002 $2 doi
035    __
$a (PubMed)20951204
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Tichá, Olga $u Department of Clinical Immunology and Allergology, St. Anne's Faculty Hospital, Masaryk University, Brno, Czech Republic. olga.ticha@fnusa.cz $7 xx0199420
245    10
$a Monitoring of CD38high expression in peripheral blood CD8+ lymphocytes in patients after kidney transplantation as a marker of cytomegalovirus infection / $c Olga Ticha, Martina Stouracova, Milan Kuman, Pavel Studenik, Tomas Freiberger, Jiri Litzman
520    9_
$a BACKGROUND: Cytomegalovirus (CMV) infection is a life-threatening complication after solid organ transplantation. It usually appears in the first months after transplantation as a consequence of immunosuppression. The goal of this study was to evaluate the clinical significance of CD38(high)/CD3(+)8(+) percentages in the detection of CMV infection in patients after kidney transplantation. METHODS: In this retrospective study, 269 patients were monitored 2-3 months after renal transplantation for the percentage of CD38(high)/CD3(+)8(+) lymphocytes estimated by flow cytometry and for the number of CMV DNA copies in peripheral blood using a real-time polymerase chain reaction. RESULTS: CMV infection was diagnosed in 12 (4.5%) patients between the 31st and 63rd days after transplantation, and all of them had percentages of CD38(high)/CD3(+)8(+) T lymphocytes above 20%. In 4 of them, CMV DNAemia in peripheral blood was not detected, and 2 of these suffered from tissue-invasive CMV disease. In 7 patients with CMV DNAemia, the CD38(high)/CD3(+)8(+) T lymphocyte percentage did not exceed 20%, and these patients did not develop CMV infection requiring antiviral treatment. In 23 additional patients, a CD38(high)/CD3(+)CD8(+) percentage above 20% was recorded without CMV DNAemia. All of the remaining 234 patients never exceeded the arbitrary limit of 20%. The estimated sensitivity and specificity were 100% and 91% using clinical decision on the presence of CMV infection as a reference value, respectively. The estimated negative predictive value was 100%; however, the estimated positive predictive value was quite low (34%). CONCLUSIONS: The CD38(high)/CD3(+)8(+) lymphocyte percentage seems to be a useful additional diagnostic marker for CMV infection in patients after kidney transplantation, especially when patients are in the risk of a tissue-invasive disease when CMV DNA copies may not be detectable in peripheral blood.
650    _2
$a dospělí $7 D000328
650    _2
$a antigeny CD38 $x biosyntéza $7 D051997
650    _2
$a biologické markery $x metabolismus $7 D015415
650    _2
$a CD8-pozitivní T-lymfocyty $x imunologie $x metabolismus $x patologie $7 D018414
650    _2
$a Cytomegalovirus $x patogenita $x fyziologie $7 D003587
650    _2
$a cytomegalovirové infekce $x komplikace $x diagnóza $x imunologie $7 D003586
650    _2
$a rejekce štěpu $x komplikace $x diagnóza $x imunologie $7 D006084
650    _2
$a lidé $7 D006801
650    _2
$a transplantace ledvin $7 D016030
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a monitorování fyziologických funkcí $x metody $7 D008991
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a senzitivita a specificita $7 D012680
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Štouračová, Martina $u Department of Clinical Immunology and Allergology, St. Anne's Faculty Hospital, Masaryk University, Brno, Czech Republic $7 xx0079456
700    1_
$a Kuman, Milan, $u Centre for Cardiovascular Surgery and Transplantation Brno, Brno, Czech Republic $d 1953- $7 xx0176002
700    1_
$a Studeník, Pavel, $u Centre for Cardiovascular Surgery and Transplantation Brno, Brno, Czech Republic $d 1952-2019 $7 nlk20050170294
700    1_
$a Freiberger, Tomáš $u Centre for Cardiovascular Surgery and Transplantation Brno, Brno, Czech Republic $7 xx0071641
700    1_
$a Litzman, Jiří, $u Department of Clinical Immunology and Allergology, St. Anne's Faculty Hospital, Masaryk University, Brno, Czech Republic $7 xx0000488 $d 1958-
773    0_
$w MED00006022 $t Transplant immunology $x 1878-5492 $g Roč. 24, č. 1 (2010), s. 50-56
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20951204 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120816 $b ABA008
991    __
$a 20160301180840 $b ABA008
999    __
$a ok $b bmc $g 949361 $s 784665
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 24 $c 1 $d 50-56 $e 20101014 $i 1878-5492 $m Transplant immunology $n Transpl Immunol $x MED00006022
GRA    __
$a NS9894 $p MZ0
LZP    __
$b NLK112 $a Pubmed-20120816/11/02

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...